BSE · 541269 · Chemicals
Chemfab Alkalis Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹73 Cr with net profit ₹5 Cr — a 6.61% net margin, versus -1.07% the period before.
Shareholding
As of 2026-06-30
- Promoter72.13%
- Public27.75%
- FII0.04%
- DII0.07%
10,650 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.57× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #83 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,71,026 Cr | 85.88 | 27.27 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,57,140 Cr | 59.33 | 14.52 | 22.61% | 17.2% |
| SRF Ltd. | ₹73,516 Cr | 32.81 | 5.25 | 13.07% | 13.01% |
| Linde India Limited | ₹51,934 Cr | 95.04 | 12.18 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹49,802 Cr | 80.63 | 6.38 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹41,875 Cr | 52.66 | 10.54 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹38,283 Cr | 31.29 | 3.42 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹32,939 Cr | 41.21 | 7 | 15.96% | 16.07% |
| Deepak Nitrite Ltd. | ₹21,693 Cr | 27.38 | 3.72 | 9.43% | 9.13% |
| Aether Industries Limited | ₹21,278 Cr | 88.67 | 8.67 | 8.94% | 19.11% |
| Chemfab Alkalis Ltd.(this company) | ₹512 Cr | 1111.76 | 1.36 | -0.91% | -0.09% |
AI analysis
AI-generated · google/gemini-2.5-flashChemfab Alkalis Ltd. (symbol: 541269) operates in the Chemicals sector. The company has a market capitalisation of Rs 513 Cr. Its book value is Rs 261.17 and it has a debt-to-equity ratio of 0.14. For the financial year ending Mar 2025, revenue was Rs 341.49 Cr with a net loss of Rs 6.94 Cr.
Positives
- +The debt-to-equity ratio is low at 0.14, indicating a sound financial structure.
- +Promoter holding is high at 72.13% as of June 30, 2026.
- +The company has not reported any promoter pledges.
Negatives
- −The profit margin is significantly negative at -110.28%.
- −Return on Equity (ROE) is negative at -91.27%.
- −Earnings per share (EPS) for the financial year ending Mar 2025 is negative at -Rs 4.84.
- −The company is currently under ESM Stage 1 surveillance.
- −The latest reported quarterly net profit for Dec 2025 was negative at -Rs 4.45 Cr.
Financial Performance
For the financial year ending Mar 2025, Chemfab Alkalis Ltd. reported a revenue of Rs 341.49 Cr, marking a revenue growth of 2.16%. The company posted a net profit of -Rs 6.94 Cr for the same period. In the most recent quarter ending Mar 2026, the company recorded a revenue of Rs 74.78 Cr and a net profit of Rs 0.48 Cr.
Profitability & Returns
Chemfab Alkalis Ltd. had a negative profit margin of -110.28%. The Return on Equity (ROE) was -91.27%, and the Return on Capital Employed (ROCE) stood at 1.49%. The company's EPS for the financial year ending Mar 2025 was -Rs 4.84.
Balance Sheet
The company's book value per share is Rs 261.17. Chemfab Alkalis Ltd. has a debt-to-equity ratio of 0.14, indicating a low level of debt relative to its equity. The company does not have any promoter pledges reported.
Ownership & Pledges
As of June 30, 2026, promoters held 72.13% of the company's shares. Public shareholding was 27.75%, while FIIs held 3.63% and DIIs held 7.45%. Institutions collectively held 11.08% of the shares. There were no promoter pledges reported.
Regulatory & Surveillance
Chemfab Alkalis Ltd. is currently under ESM (Enhanced Surveillance Measure) Stage 1, a regulatory measure implemented by exchanges for securities exhibiting specific risk parameters.
Data as of — price: 2026-09-17 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.